APA (7th ed.) Citation

B, H., M, K., D, C., I, F., CD, K., C, G., . . . EC, K. (2024). Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study. Rheumatology and therapy, 11(6), 1629. https://doi.org/10.1007/s40744-024-00719-5

Chicago Style (17th ed.) Citation

B, Haraoui, et al. "Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study." Rheumatology and Therapy 11, no. 6 (2024): 1629. https://doi.org/10.1007/s40744-024-00719-5.

MLA (9th ed.) Citation

B, Haraoui, et al. "Tofacitinib Safety and Effectiveness in Canadian Patients with Rheumatoid Arthritis by Cardiovascular Risk Enrichment: Subanalysis of the CANTORAL Study." Rheumatology and Therapy, vol. 11, no. 6, 2024, p. 1629, https://doi.org/10.1007/s40744-024-00719-5.